ENA Respiratory has welcomed $2.98 million in funding from Biointelect Venturer to support its first Australian study of INNA ...

Vitrafy Life Sciences has secured its first foothold in the United States cell and gene therapy market through an agreement ...

Prescient Therapeutics has reached an important enrolment milestone in its Phase 2a trial of PTX-100 for patients with ...

Telix Pharmaceuticals has completed enrolment in its pivotal BiPASS trial, moving the Australian company closer to testing ...

OncoSil Medical has moved to secure a Medicare reimbursement pathway for its targeted internal radiation device in the United States, following the Food and Drug Administration’s humanitarian approval ...

Alterity Therapeutics has secured an underwriting agreement that could provide at least $4.2 million in additional funding as the company prepares to begin its planned Phase 3 clinical trial of ATH434 ...

Melbourne company Cartherics is joining forces with the Zucker Institute at the Medical University of South Carolina to investigate whether a novel antibody can strengthen next-generation immune cell ...

Avecho Biotechnology has restarted recruitment for the final stage of its pivotal Phase 3 trial of a cannabidiol capsule designed to treat insomnia, after an independent review found the study could ...

Percheron Therapeutics has secured firm commitments for a $2.3 million institutional placement, providing what the company says is full funding for a new clinical trial of its lead drug candidate, ...

Tetratherix has exported its first commercial shipment of Tetramatrix polymer to the United States, marking the start of product revenue for the ASX-listed company’s Precision Medicine franchise. The ...

Six Australian companies developing vaccines, antiviral treatments, and vaccine-production technologies will share $10.48 million in Biointelect Venture's first funding round. The Venturer is a ...

Nanosonics has entered financial year 2027 with continued growth from its trophon disinfection business, while advancing the commercial rollout of its CORIS endoscope reprocessing platform and ...